Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
23.64%
operating margin TTM
24.1%
revenue TTM
735.15 Million
revenue per share TTM
4.41$
valuation ratios | |
|---|---|
| pe ratio | 11.81 |
| peg ratio | 0.16 |
| price to book ratio | 3.65 |
| price to sales ratio | 2.81 |
| enterprise value multiple | 30.33 |
| price fair value | 3.65 |
profitability ratios | |
|---|---|
| gross profit margin | 91.46% |
| operating profit margin | 24.1% |
| pretax profit margin | 26.94% |
| net profit margin | 23.64% |
| return on assets | 19.07% |
| return on equity | 39.54% |
| return on capital employed | 29.11% |
liquidity ratio | |
|---|---|
| current ratio | 2.38 |
| quick ratio | 2.32 |
| cash ratio | 0.81 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 97.89 |
| operating cycle | 137.79 |
| days of payables outstanding | 72.21 |
| cash conversion cycle | 65.57 |
| receivables turnover | 9.15 |
| payables turnover | 5.05 |
| inventory turnover | 3.73 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.07 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 3.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.95 |
| cash per share | 4.56 |
| operating cash flow per share | 0.95 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 3.03 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 301.57 |
Frequently Asked Questions
When was the last time ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported earnings?
ACADIA Pharmaceuticals Inc. (ACAD) published its most recent earnings results on 07-11-2024.
What is ACADIA Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)'s trailing twelve months ROE is 39.54%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ACADIA Pharmaceuticals Inc. (ACAD) currently has a ROA of 19.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ACAD's net profit margin stand at?
ACAD reported a profit margin of 23.64% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ACAD's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.38 in the most recent quarter. The quick ratio stood at 2.32, with a Debt/Eq ratio of 0.07.